TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia.
McLean TW, Ringold S, Neuberg D, Stegmaier K, Tantravahi R, Ritz J, Koeffler HP, Takeuchi S, Janssen JW, Seriu T, Bartram CR, Sallan SE, Gilliland DG, Golub TR.
McLean TW, et al. Among authors: janssen jw.
Blood. 1996 Dec 1;88(11):4252-8.
Blood. 1996.
PMID: 8943861
Free article.